This work aimed to quantify and compare real‐world treatment eligibility according to the AASLD and expert panel‐derived criteria and to evaluate classification of patients with available liver histology.
Abstract
Non‐invasive tests (NITs) are increasingly used to guide patient selection for pharmacological treatment of metabolic dysfunction‐associated steatohepatitis (MASH). We aimed to quantify and compare real‐world treatment eligibility according to the AASLD and expert panel‐derived criteria and to evaluate classification of patients with available liver histology.
Adults with obesity are at increased risk of metabolic dysfunction‐associated steatotic liver disease (MASLD)‐related fibrosis, but the diagnostic performance of non‐invasive tests (NITs) in this population remains uncertain. This meta‐analysis evaluated NITs for detecting significant (≥F2) and advanced (≥F3) fibrosis...
Patricia M. Ortega, L. Sabatella, P. Manousou et al.· Diabetes, obesity and metabo...· 0 citations
Criteria to define difficult‐to‐treat (DTT) inflammatory bowel disease (IBD) have recently been proposed, yet the inclusion and participation of patients with DTT‐IBD in randomized controlled trials (RCTs) are heterogeneous and poorly defined.
T. Parigi, V. Solitano, H. Mekonnen et al.· Alimentary Pharmacology and...· 0 citations
Puri and colleagues report a nationwide assessment of lipid-lowering treatment among 9,658 Indian patients with coronary artery disease. 1 They document poor low-density lipoprotein cholesterol (LDL-C) goal attainment, low use of combination therapy
Shambo Samrat Samajdar, Shashank R. Joshi· JACC: Asia· 0 citations
Drug‐induced ductopenia (DID) represents a rare histological phenotype of drug‐induced liver injury (DILI), typically associated with prolonged cholestasis and historically linked to poor outcomes. This study aimed to characterize the clinical presentation, histological features and outcomes of DID using data from the...
F. Bessone, N. Hernández, M. Schinoni et al.· Liver international (Print)· 0 citations
The publication of the joint EASL-EASD-EASO guidance on the use of resmetirom and semaglutide as MASH-targeted therapy represents a watershed moment in hepatology [...]
To address the paucity of data on outcomes and costs of status epilepticus (SE) following the updated 2015 International League Against Epilepsy (ILAE) definition and changes in clinical practice guidelines in Germany.
C. Jünemann, Meike Menche, Jens-Peter Reese et al.· European Journal of Neurolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.